Bradley Saenger
2019
In 2019, Bradley Saenger earned a total compensation of $578.1K as Chief Financial Officer at Tonix Pharmaceuticals Holding, a 6% decrease compared to previous year.
Compensation breakdown
Bonus | $80,850 |
---|---|
Option Awards | $112,262 |
Salary | $385,000 |
Total | $578,112 |
Saenger received $385K in salary, accounting for 67% of the total pay in 2019.
Saenger also received $80.9K in bonus and $112.3K in option awards.
Rankings
In 2019, Bradley Saenger's compensation ranked 11,318th out of 13,971 executives tracked by ExecPay. In other words, Saenger earned more than 19.0% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 11,318 | 19th |
Manufacturing | 4,587 | 20th |
Chemicals And Allied Products | 1,804 | 18th |
Drugs | 1,552 | 18th |
Pharmaceutical Preparations | 1,149 | 18th |
Saenger's colleagues
We found two more compensation records of executives who worked with Bradley Saenger at Tonix Pharmaceuticals Holding in 2019.
News
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2023 pay falls 55% to $2.1M
April 15, 2024
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2022 pay falls 41% to $4.6M
March 17, 2023
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2021 pay jumps 99% to $7.7M
March 18, 2022
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2020 pay jumps 201% to $3.9M
March 31, 2021
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2019 pay slips 13% to $1.3M
March 30, 2020
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2018 pay jumps 157% to $1.5M
March 18, 2019